Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Biogen and Bio-Thera Report Progress On Tocilizumab
Firms Reveal Positive Phase III Data For Actemra/RoActemra Rival
Jun 13 2022
•
By
David Wallace
Phase III results for tocilizumab have been positive • Source: Shutterstock
More from Biosimilars
More from Products